Ssuuna, Charles
Galiwango, Ronald Moses
Kankaka, Edward Nelson
Kagaayi, Joseph
Ndyanabo, Anthony
Kigozi, Godfrey
Nakigozi, Gertrude
Lutalo, Tom
Ssekubugu, Robert
Wasswa, John Bosco
Mayinja, Anthony
Nakibuuka, Martina Cathy
Jamiru, Samiri
Oketch, John Baptist
Muwanga, Edward
Chang, Larry William
Grabowski, Mary Kate
Wawer, Maria
Gray, Ronald
Anderson, Mark
Stec, Michael
Cloherty, Gavin
Laeyendecker, Oliver
Reynolds, Steven James
Quinn, Thomas C.
Serwadda, David
Funding for this research was provided by:
Government of Uganda through Makerere University Research and Innovations Fund (RIF/COVID/075, RIF/COVID/075, RIF/COVID/075, RIF/COVID/075, RIF/COVID/075)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
United States National Institutes of Health Fogarty International Center (D43TW010557)
Article History
Received: 8 October 2021
Accepted: 11 February 2022
First Online: 21 February 2022
Declarations
:
: All methods of this study were carried out in accordance with the Uganda National Council for Science and Technology (UNCST) guidelines, the body that regulates research in Uganda. It was approved by the Uganda Virus Research Institute’s Research Ethics Committee (Ref. GC/127/20/08/785), registered, and cleared by the UNCST (registration number HS878ES). Written informed consent was obtained from participants before blood specimens and other data were collected. Also, only archived plasma specimens (collected prior to confirmation of the first COVID-19 case) from Rakai Community Cohort Study (RCCS) participants that had provided prior written informed consent for use of their blood specimens in future studies were retrieved to assess prior SARS-CoV-2 exposure in Uganda. All participants were aged 18 years and above. No informed consent from ‘Legally authorized representatives/parents’ of minors below 16 years of age was thus required.
: Not applicable.
: The authors declare that they have no competing interests.